Table 2.
Distribution of underlying diseases and their crude association with in-hospital mortality between sex groups in COVID-19 patient
| Variables | Male (n=544) | Female (n:447) | ||||
|---|---|---|---|---|---|---|
| Survived | Dead | P | Survived | Dead | P | |
| DM | 112(28.9) | 50(31.8) | 0.50 | 106(30.5) | 35(35.0) | 0.39 |
| CNS | 44(11.4) | 32(20.4) | 0.006* | 19(5.5) | 12(12.1) | 0.02* |
| Hypertension | 121(31.3) | 76(48.4) | <0.001* | 148(42.7) | 62(62.0) | <0.001* |
| CKD | 36(9.3) | 16(10.2) | 0.74 | 34(9.8) | 16(16.0) | 0.08 |
| Cancer | 9(2.3) | 7(4.5) | 0.18 | 20(5.8) | 6(6.0) | 0.92 |
| Hyperlipidemia | 19(4.9) | 12(7.6) | 0.213 | 21(6.1) | 10(10.0) | 0.17 |
| ISD | 9(2.3) | 7(4.5) | 0.18 | 16(4.6) | 5(5.0) | 0.87 |
| RD | 27(7.0) | 16(10.2) | 0.20 | 31(8.9) | 13(13.0) | 0.22 |
| CD | 5(1.3) | 4(2.5) | 0.29 | 10(2.9) | 2(2.0) | 0.63 |
| CAD | 77(19.9) | 36(22.9) | 0.42 | 51(14.7) | 30(30.0) | <0.001* |
| Coronary revisualization | ||||||
| CABG | 31(8.0) | 12(7.6) | 0.82 | 7(2.0) | 7(7.1) | 0.003* |
| Angioplasty | 24(6.2%) | 12(7.6%) | 11(3.2%) | 8(8.2%) | ||
Data are presented as number (%). DM: Diabetes mellitus; CNS: Central nervous system disorders; CKD: Chronic kidney Disease; ISD: Immunosuppressive disorders; RD: Respiratory diseases; CD: Congenital Disorders; CAD: Coronary Artery Disease; CABG: Coronary Artery Bypass Graft; P<0.05 was considered statistically significant.